| Name | Title | Contact Details |
|---|
NAVEOS® is the proven leader in maximizing the value of governmental program reimbursements for healthcare providers. Since 2005, our superior approach to data analytics has enabled healthcare providers to realize almost one billion dollars in additional DSH/340B reimbursement payments. NAVEOS® has developed a fully integrated DSH/340B software solution with a national eligibility verification network for both Medicare and Medicaid data. This system, which is the most robust in the industry, uses sophisticated algorithms to match eligibility data with patient data, applies the most up to date Federal and State regulatory parameters, then builds comprehensive deliverables for supporting DSH/340B filings. By leveraging our state-of-the-art technology and unsurpassed domain expertise, we generate best-in-class deliverables that yield impressive value and achieve a stellar (99.7%) audit acceptance rate.
Nars Cosmetics, Inc, division of Shiseido Cosmetics America Ltd. is one of the leading providers in Healthcare, Pharmaceuticals, and Biotech. It is based in New York, NY. To find more information about Nars Cosmetics, Inc, division of Shiseido Cosmetics America Ltd., please visit www.narscosmetics.com
CMC's Department of Pediatrics and the hospital's administration are committed to quality care for children, said Steve Carlson, CMC's president and chief executive officer.
PERL Research is a Huntsville, AL-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Premier Cancer Treatment throughout Arizona - Phoenix - Tucson - Chemotherapy, Radiation Therapy, Gynecologic, Clinical Research